/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/1rYGA7MkLO1qtEMFJVjqp8Zh0Ydh1WWLkFT8TY8_cbygHkXMIOm3krbX1MU2KLsB-wWIIoJt29DLCiNDd33_wBfCwcEGBA.jpeg)
Committed to Clinical Research
At Galenus Group, we’re committed to providing the most exceptional and innovative care in Clinical Research with a compassionate and professional atmosphere. Our mission is to contribute to the development of new treatments in the pharmaceutical field.
The world faces multiple health challenges, ranging from outbreaks of vaccine-preventable diseases such as measles and diphtheria, increasing reports of drug-resistant pathogens, increasing rates of obesity and sedentary lifestyles, to health effects of environmental pollution and climate change and multiple humanitarian and health crises.
Noncommunicable diseases, such as metabolic syndrome, diabetes, cancer, and heart disease, are responsible for more than 70% of all annual deaths worldwide, or 41 million people. This includes 15 million people who die prematurely, between the ages of 30 and 69 years old.
With many years of experience, we achieved a well-deserved reputation in the industry. Since the very beginning, we have had the philosophy that our patients come first. No matter why you’re visiting us, we provide comprehensive and excellent care. Please find out more about our Providers & Investigators and let us take care of you.
/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/LpSNdweA29EXeRLcLMQ5c520fsONnlQ0T8LbTFzf4_mflbTmKZ8_ATFbmwpqjU1fVSGUyXoj7gf-4l594Gew6MJlakORMg.jpeg)
/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/3gWGdOQZi_Ww_aCrAUdTzuqE62X9TeCCrFFLC6pf7mf2UmmMEMIjyWgpK5rggxcuK_UxZ40GEP58w8pqRBt1rzJI4ppGH9k.png)
/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/k2fRJGjtYpn-1peExS4Z4hueorvXCPj_ldKIIUMreJehbjH583kkwBR53SLi4FqO4ivF5XMTkGpUmZFpVptrZaIj8BduNw.png)
/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/h7Jc8BW-oHFZptZ8qaiYOjxlL7ST4R9RY-bwwUyRPk_Z48wDgjgzLy04Bt1RKJF0VmHS3U4VdstnGlE3n8Web63iDk3BDA2i.jpeg)
/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/fdoTtqib619ucQJ9hqdTNO7F1vaTzoyvcamTiGXfiHM-Lz0PeGL10FkLXmKqtpBC030FWydrLdd5aJYHbINwhdzjmkD1fUA.jpeg)
/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/LRZ0BZBsohW1G4Qu_wYnpCY3iy_T2vDz9CGs-5NMFVjEp430Kaw0XKA9F2TO3E5ALKKdB72EOoD9l6AnifRTvuKhbexPR8GL.jpeg)
/sc-assets/prd/practices/ca529f0f-095c-4acf-b1a5-60399d2c43bb/cTfqO-QYTjkfTLsor-pCrO135sA2C88cQHDm4_RXu1b6ZWgEd9wTupYBZgh-Q4-kGbQPrm1TqJ4c3C8PtOqDS26xSpUNDQ.jpeg)